Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia

scientific article

Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/138161212799958594
P698PubMed publication ID22280435
P5875ResearchGate publication ID221780361

P50authorStephen StahlQ24006564
P2093author name stringThomas L Schwartz
Shilpa Sachdeva
P433issue12
P921main subjectschizophreniaQ41112
P304page(s)1580-1592
P577publication date2012-01-01
P1433published inCurrent Pharmaceutical DesignQ5195068
P1476titleGenetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia
P478volume18

Reverse relations

cites work (P2860)
Q33607904A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway
Q38122300A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo
Q34283319Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.
Q35626044Altered neuronal excitability underlies impaired hippocampal function in an animal model of psychosis
Q39580232Beyond dopamine: glutamate as a target for future antipsychotics.
Q38024032Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.
Q37561567Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.
Q38820530DNA Damage in Major Psychiatric Diseases
Q35699606Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site
Q61814348EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis
Q38063195Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
Q24202544Memantine for schizophrenia
Q52648016Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome.
Q30397669NMDA Receptors Mediate Stimulus-Timing-Dependent Plasticity and Neural Synchrony in the Dorsal Cochlear Nucleus
Q54989276Study of the Effect of Memantine on Negative Sign in Patients with Schizophrenia and Schizoaffective Disorders.
Q39020275Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Q38223276Targeting of NMDA receptors in new treatments for schizophrenia
Q48138640The effects of N-Methyl-D-Aspartate receptor blockade during the early neurodevelopmental period on emotional behaviors and cognitive functions of adolescent Wistar rats
Q38213709The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment
Q38232366The neurobiology and treatment of first-episode schizophrenia

Search more.